$50.3 M

OGEN Mkt cap, 31-Dec-2021
Oragenics Net income (Q1, 2021)-5.2 M
Oragenics EBIT (Q1, 2021)-5.2 M
Oragenics Cash, 31-Mar-202136.5 M
Oragenics EV14.5 M
Get notified regarding key financial metrics and revenue changes at OragenicsLearn more
Banner background

Oragenics Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

347.6k350.4k380.5k256.4k176.4k167.7k253.4k214.7k303.8k201.0k363.8k242.0k329.8k262.3k

Cost of goods sold

328.8k134.4k198.2k112.3k63.9k86.7k113.4k79.8k125.6k73.7k168.0k86.8k134.6k90.0k

Gross profit

18.8k215.9k182.3k144.1k112.5k81.0k140.0k134.9k178.1k127.3k195.8k155.3k195.2k172.3k

Gross profit Margin, %

5%62%48%56%64%48%55%63%59%63%54%64%59%66%

R&D expense

631.4k562.7k353.2k6.2m745.4k637.0k6.9m1.0m903.3k597.0k676.6k5.6m1.2m1.2m812.6k924.8k1.1m605.4k996.5k1.3m1.6m2.4m3.9m3.1m3.7m11.5m3.3m

General and administrative expense

1.7m1.4m1.3m835.5k1.1m1.5m2.6m767.4k1.2m565.1k815.5k873.6k853.9k994.4k920.7k1.1m865.2k791.3k925.0k1.0m1.2m980.4k1.0m852.8k1.5m808.3k2.0m

Operating expense total

2.3m1.9m1.7m7.0m1.8m2.2m9.5m1.8m2.1m1.2m1.5m6.5m2.0m2.2m1.7m2.0m2.0m1.4m1.9m2.3m2.8m3.4m4.9m3.9m5.2m12.4m5.2m

EBIT

(2.3m)(1.7m)(1.5m)(6.9m)(1.7m)(2.1m)(9.3m)(1.6m)(1.9m)(1.0m)(1.3m)(6.3m)(1.8m)(2.1m)(1.7m)(2.0m)(2.0m)(1.4m)(1.9m)(2.1m)(2.8m)(3.4m)(4.9m)(3.9m)(5.2m)(12.4m)(5.2m)

EBIT margin, %

(663%)(488%)(389%)(2679%)(984%)(1238%)(3681%)(768%)(626%)(515%)(356%)(2615%)(555%)(787%)

Interest expense

67.7k96.7k138.3k60.1k949.0844.041.08.1k7.0k5.3k3.5k5.2k34.2k647.0280.021.1k5.1k175.8k145.7k2.3k664.06.5k68.5k98.4k83.9k

Interest income

200.0329.0383.01.2k6.4k5.1k3.6k10.8k9.7k8.7k6.6k5.8k5.0k2.6k1.4k18.5k1.9k1.8k3.0k3.5k3.3k9.1k70.1k99.4k86.7k44.5k16.5k20.0k

Pre tax profit

(2.4m)(1.8m)(1.6m)(6.9m)(1.6m)(2.1m)(9.3m)(1.6m)(1.9m)(1.0m)(1.3m)(6.3m)(1.9m)(2.1m)(1.7m)(2.0m)(2.0m)(1.2m)(2.1m)(2.1m)(2.3m)(2.8m)(3.3m)(4.8m)(3.8m)(5.2m)(12.3m)(5.2m)

Income tax expense

1.4k(212.0)152.01.1k3.8k3.0k2.0k2.2k1.5k2.0k

Net Income

(2.4m)(1.8m)(1.6m)(6.9m)(1.6m)(2.1m)(9.3m)(1.6m)(1.9m)(1.0m)(1.3m)(6.3m)(1.9m)(2.1m)(312.6k)(2.0m)(2.0m)(1.2m)(2.1m)(2.1m)(2.3m)(2.8m)(3.3m)(4.8m)(3.8m)(5.2m)(12.3m)(5.2m)

Oragenics Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Cash

967.9k1.1m11.8m8.4m6.4m8.3m14.6m12.9m11.8m9.1m8.0m6.7m3.4m5.5m5.1m2.2m2.1m2.9m4.8m3.9m13.8m29.3m25.7m22.3m14.4m9.6m36.5m

Accounts Receivable

55.1k44.3k63.3k39.4k72.4k55.4k49.6k58.9k42.9k22.8k26.3k29.6k26.8k19.4k32.7k

Prepaid Expenses

168.3k123.9k152.3k236.4k210.5k302.4k227.0k154.4k144.6k221.6k133.8k90.4k173.3k192.9k111.8k171.9k106.3k517.7k769.6k722.6k1.3m1.7m1.7m355.4k555.5k328.7k295.5k222.8k

Inventories

500.6k465.5k363.0k353.8k279.9k117.3k303.0k223.3k265.9k239.0k263.9k377.0k364.1k299.3k241.5k

Current Assets

1.1m1.1m1.8m1.9m12.5m8.8m7.0m8.8m15.1m13.3m12.3m9.6m8.5m7.2m3.8m6.0m5.3m2.3m4.5m5.1m5.5m5.2m15.5m31.1m26.1m22.8m14.7m9.9m36.7m

PP&E

188.1k168.1k129.1k111.5k92.9k63.6k48.9k38.2k39.3k31.9k26.3k167.7k170.7k159.3k122.4k104.2k107.1k69.4k51.8k34.1k14.0k10.6k63.5k103.6k101.6k89.7k79.7k67.3k30.4k

Total Assets

1.3m1.2m1.9m2.0m12.6m8.8m7.1m8.8m15.1m13.3m12.3m9.8m8.7m7.4m4.0m6.1m5.4m2.4m4.6m5.1m5.5m5.2m15.5m31.3m26.9m23.7m15.6m10.7m37.4m

Accounts Payable

1.6m1.5m1.3m1.3m1.4m1.1m1.2m2.4m807.4k703.2k604.4k509.3k548.7k761.8k986.7k693.5k786.2k1.1m1.1m1.6m1.1m1.5m1.4m2.0m1.7m1.9m1.8m1.1m572.7k

Short-term debt

70.8k302.8k296.1k

Current Liabilities

1.8m7.8m1.5m1.4m1.8m1.2m1.4m4.5m938.1k777.9k739.5k606.0k5.6m5.9m1.1m897.8k909.3k1.2m1.1m1.7m1.2m1.6m1.6m2.2m1.9m2.2m2.0m1.4m868.9k

Long-term debt

616.2k586.2k627.7k583.9k446.5k

Non-Current Liabilities

3.0m2.4m616.2k586.2k627.7k583.9k446.5k

Total Debt

616.2k586.2k698.6k886.6k742.6k

Total Liabilities

6.3m7.8m

Common Stock

5.7k5.7k12.2k16.6k27.2k27.5k27.5k30.2k36.1k36.2k36.2k36.4k36.4k36.5k40.1k49.1k49.1k49.3k49.3k49.3k5.2k6.1k18.4k46.1k46.1k46.1k46.1k55.4k115.6k

Preferred Stock

482.2k1.2m6.1m6.1m6.8m6.5m6.5m6.5m7.2m7.2m2.7m

Additional Paid-in Capital

32.3m32.5m42.3m48.1m62.9m63.3m63.4m71.4m86.0m86.2m86.2m86.4m86.6m86.9m92.6m97.2m97.4m97.8m97.8m99.7m101.8m103.4m115.8m137.7m137.8m138.0m138.9m147.1m194.1m

Retained Earnings

(37.2m)(39.1m)(42.6m)(49.5m)(52.1m)(55.7m)(57.8m)(67.1m)(71.8m)(73.7m)(74.7m)(77.2m)(83.6m)(85.4m)(89.7m)(90.0m)(92.0m)(96.7m)(97.9m)(99.9m)(103.6m)(105.9m)(108.6m)(115.1m)(119.9m)(123.8m)(133.2m)(145.5m)(160.8m)

Total Equity

(5.0m)(6.6m)(314.3k)(1.4m)10.8m7.6m5.7m4.4m14.2m12.6m11.6m9.2m3.1m1.5m2.9m5.2m4.5m1.2m505.5k1.0m4.3m3.7m14.0m29.1m24.4m20.8m12.9m8.8m36.1m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

-0.3 x-0.2 x-6.2 x-1.4 x1.2 x1.2 x1.2 x2 x1.1 x1.1 x1.1 x1.1 x2.8 x4.9 x1.4 x1.2 x1.2 x2 x9.1 x5.1 x1.3 x1.4 x1.1 x1.1 x1.1 x1.1 x1.2 x1.2 x1 x

Oragenics Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Net Income

(3.9m)(5.7m)(1.6m)(8.5m)(11.1m)(1.6m)(3.7m)(13.0m)(1.6m)(3.5m)(4.6m)(1.3m)(7.6m)(9.5m)(2.1m)(2.4m)(4.3m)(2.0m)(3.2m)(5.3m)(2.1m)(4.4m)(7.2m)(3.3m)(8.1m)(12.0m)(5.2m)(17.5m)(5.2m)

Depreciation and Amortization

40.1k60.1k19.6k37.2k55.8k21.0k42.1k64.0k6.5k13.3k20.1k13.9k32.5k52.5k18.3k36.5k55.4k18.0k35.7k53.3k7.7k11.0k18.4k12.9k26.2k44.3k13.1k26.0k12.7k

Accounts Receivable

67.9k78.6k29.3k53.2k20.3k14.4k20.2k10.9k21.6k41.6k38.1k(14.0k)(11.2k)(3.8k)(11.6k)

Inventories

(233.9k)(198.8k)112.6k121.8k195.6k6.9k61.2k140.9k22.5k49.4k24.5k62.2k75.1k139.9k80.0k

Accounts Payable

96.4k29.0k11.7k1.7k(104.6k)(75.3k)64.9k(280.4k)(102.6k)(206.7k)(305.6k)(200.9k)(161.5k)51.6k17.0k(137.5k)(44.8k)(174.6k)(216.1k)317.2k293.4k719.1k548.5k931.8k697.7k851.4k245.3k(484.2k)(364.3k)

Cash From Operating Activities

(2.6m)(4.1m)(1.1m)(2.3m)(3.5m)(1.6m)(3.6m)(5.5m)(1.6m)(3.3m)(4.4m)(1.3m)(2.2m)(3.5m)(1.7m)(3.5m)(5.1m)(1.9m)(3.7m)(5.0m)(1.4m)(3.6m)(6.1m)(2.2m)(5.7m)(9.1m)(3.8m)(8.7m)(4.3m)

Purchases of PP&E

(6.4k)(17.6k)(18.9k)(18.9k)(20.1k)(72.2k)(93.9k)(102.5k)(27.2k)(60.2k)(11.4k)(11.4k)

Cash From Investing Activities

(6.4k)(17.6k)(18.9k)(18.5k)(19.7k)(72.2k)(93.9k)(101.2k)1.3m1.7m(60.2k)(11.4k)(11.4k)

Short-term Borrowings

(96.8k)(34.4k)(79.0k)(113.5k)(179.4k)(73.0k)(143.9k)(113.3k)

Cash From Financing Activities

2.5m4.0m1.9m3.3m15.1m5.3k29.1k3.9m(34.4k)(79.0k)(113.5k)(34.8k)(79.5k)(113.8k)(33.9k)2.6m3.5m(5.0k)1.7m3.8m(41.6k)1.4m13.8m11.4m11.2m11.2m(73.0k)16.7k23.2m

Net Change in Cash

(132.1k)(132.1k)796.2k958.7k11.6m(1.6m)(3.6m)(1.7m)(1.6m)(3.4m)(4.5m)(1.4m)(2.4m)(3.7m)(1.7m)272.3k76.0k(1.9m)(2.0m)(1.2m)(1.4m)(2.2m)7.6m9.1m5.5m2.1m(3.9m)(8.6m)18.9m

Interest Paid

3.0k4.3k447.01.3k2.9k982.01.8k3.1k599.01.6k3.0k606.01.5k1.2k771.0885.02.8k801.01.6k3.0k4.5k1.5k3.6k1.3k2.0k4.5k1.7k2.4k2.6k

Oragenics Ratios

USDQ2, 2011

Financial Leverage

-0.3 x